Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 170

Sort by

Sort Order Select

Journal Articles

Health-related quality of life in Chinese multiple myeloma patients treated with daratumumab-based regimens in real world: Exploratory analysis of the MMY4032

Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Jin Lu

Blood (2025) 146 (Supplement 1): 7529.

https://doi.org/10.1182/blood-2025-7529

Published: 2025

Journal Articles

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Ting Wang, Lijuan Li, Huaquan Wang, Jia Song, Hui LIU, Yihao Wang, Liyan Li, Yue Ren, Rong Fu

Blood (2025) 146 (Supplement 1): 3195.

https://doi.org/10.1182/blood-2025-3195

Published: 2025

Journal Articles

Ruxolitinib may treat aplastic anaemia by reducing levels of macrophage pyroptosis

Xintong Xu, Congwei Zhong, Xiaorui Meng, Chunyan Liu, Rong Fu

Blood (2025) 146 (Supplement 1): 1425.

https://doi.org/10.1182/blood-2025-1425

Published: 2025

Journal Articles

Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study

Blood (2025) 146 (Supplement 1): 475.

https://doi.org/10.1182/blood-2025-475

Published: 2025

Journal Articles

Construction of mindfulness based cancer rehabilitation training program for malignant hematology patients based on the Liverpool mindfulness model

Rong Fu, Jie Liu, Rongrong Wang, Jianlan Ren, Wei Zhang

Blood (2025) 146 (Supplement 1): 6423.

https://doi.org/10.1182/blood-2025-6423

Published: 2025

Journal Articles

Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study

Blood (2025) 146 (Supplement 1): 5819.

https://doi.org/10.1182/blood-2025-5819

Published: 2025

Journal Articles

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

Blood (2025) 146 (Supplement 1): 88.

https://doi.org/10.1182/blood-2025-88

Published: 2025

Journal Articles

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

Blood (2025) 146 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2025-1413

Published: 2025

Journal Articles

The role of neutrophil extracellular traps in thrombosis of paroxysmal nocturnal hemoglobinuria

Mengting Che, Hui LIU, Yan Yang, Chaomeng Wang, Liyan Li, Honglei Wang, Yingying Chen, Zhaoyun Liu, Lijuan Li, Rong Fu

Blood (2025) 146 (Supplement 1): 1112.

https://doi.org/10.1182/blood-2025-1112

Published: 2025

Journal Articles

Downregulation of TANK gene affects erythroid differentiation in PNH patients.

Liyan Li, Zewei Chen, Hui LIU, Zhaoyun Liu, Yingying Chen, Rong Fu

Blood (2025) 146 (Supplement 1): 1106.

https://doi.org/10.1182/blood-2025-1106

Published: 2025

Journal Articles

The efficacy and safety of luspatercept in patients with low-blasts myelodysplastic neoplasms in real world

Huijuan Jiang, Lijuan Li, Jia Song, Huaquan Wang, Yuhong Wu, Wen Qu, Jing Guan, Limin Xing, Guojin Wang, Hong Liu, Zonghong Shao, Rong Fu

Blood (2025) 146 (Supplement 1): 7400.

https://doi.org/10.1182/blood-2025-7400

Published: 2025

Journal Articles

Role of NK cells in immune escape in patients with classical paroxysmal nocturnal hemoglobinuria

Chaomeng Wang, Yan Yang, Wei Wang, Liyan Li, Mengting Che, Yingying Chen, Honglei Wang, Zhaoyun Liu, Lijuan Li, Hui LIU, Rong Fu

Blood (2025) 146 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2025-4664

Published: 2025

Journal Articles

Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma

Jing Li, Zhenyu Li, Chunrui Li, Pengcheng He, Jun Luo, Rong Fu, Liye Zhong, Hang Quach, Jay Hocking, Peter Presgrave, Xiaoyi Tang, Wen Zhang, Jinchao Gao, Luyin Ding, Peiqi Li, Hui Zhou, Peng Liu

Blood (2025) 146 (Supplement 1): 702.

https://doi.org/10.1182/blood-2025-702

Published: 2025

Journal Articles

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Blood (2025) 146 (Supplement 1): 6293.

https://doi.org/10.1182/blood-2025-6293

Published: 2025

Journal Articles

Luspatercept combined with immunosuppressive therapy reduces inflammation in aplastic anemia by inhibiting monocyte pyroptosis

Zining Wang, Nan Song, Chunyan Liu, Rong Fu

Blood (2025) 146 (Supplement 1): 4976.

https://doi.org/10.1182/blood-2025-4976

Published: 2025

Journal Articles

The role and mechanism of exosomal aminopeptidase n (APN/CD13)-mediated CTL cell dysfunction in aplastic anemia

Li Yan, Ziyu Zhan, Nan Song, Chunyan Liu, Nan Jiang, Xiaofeng Pan, Zonghong Shao, Bingnan Liu, Rong Fu

Blood (2025) 146 (Supplement 1): 4975.

https://doi.org/10.1182/blood-2025-4975

Published: 2025

Journal Articles

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Blood (2025) 146 (Supplement 1): 1878.

https://doi.org/10.1182/blood-2025-1878

Published: 2025

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Rong Fu, Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Jie Zhuo, Huijuan Jiang, Shan Gao, Yue Ren, Lijuan Li, Yihao Wang

Blood (2024) 144 (Supplement 1): 7786.

https://doi.org/10.1182/blood-2024-209056

Published: 2024

Journal Articles

Analysis of Anxiety and Depression Status and Influencing Factors in Multiple Myeloma Patients

Mengran Gao, Wei Zhang, Rong Fu

Blood (2024) 144 (Supplement 1): 7880.

https://doi.org/10.1182/blood-2024-210353

Published: 2024

Journal Articles

Single-Cell Sequencing Reveals Differential Erythroid Lineage Differentiation in Patients with PNH

Junshu Wu, Hui Liu, Liyan Li, Wei Wang, Zhaoyun Liu, Rong Fu

Blood (2024) 144 (Supplement 1): 1078.

https://doi.org/10.1182/blood-2024-208178

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Health-related quality of life in Chinese multiple myeloma patients treated with daratumumab-based regimens in real world: Exploratory analysis of the MMY4032

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Ruxolitinib may treat aplastic anaemia by reducing levels of macrophage pyroptosis

Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study

Construction of mindfulness based cancer rehabilitation training program for malignant hematology patients based on the Liverpool mindfulness model

Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

The role of neutrophil extracellular traps in thrombosis of paroxysmal nocturnal hemoglobinuria

Downregulation of TANK gene affects erythroid differentiation in PNH patients.

The efficacy and safety of luspatercept in patients with low-blasts myelodysplastic neoplasms in real world

Role of NK cells in immune escape in patients with classical paroxysmal nocturnal hemoglobinuria

Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Luspatercept combined with immunosuppressive therapy reduces inflammation in aplastic anemia by inhibiting monocyte pyroptosis

The role and mechanism of exosomal aminopeptidase n (APN/CD13)-mediated CTL cell dysfunction in aplastic anemia

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Analysis of Anxiety and Depression Status and Influencing Factors in Multiple Myeloma Patients

Single-Cell Sequencing Reveals Differential Erythroid Lineage Differentiation in Patients with PNH

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only